Agios Pharmaceuticals (AGIO) Change in Receivables (2015 - 2026)
Agios Pharmaceuticals (AGIO) reported Change in Receivables of $3.98 million for Q2 2026, up 142.4% from $1.64 million a year earlier but down 28.4% from the prior quarter.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Change in Receivables (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Agios Pharmaceuticals' Change in Receivables came in at $15.13 million; for FY2025, it came in at $6.47 million, up 397.9% from FY2024.
- Change in Receivables has a three-year compound annual growth rate of 43.1% (FY2022 to FY2025).
- By year, Change in Receivables came in at $1.3 million in FY2024 (+115.1%), $604,000 in FY2023 (-72.6%) and $2.21 million in FY2022.
- Five-year quarterly Change in Receivables spans a low of -$1.08 million in Q3 2023 and a high of $5.56 million in Q1 2026.
- Year over year, Change in Receivables gained in three of the last four quarters, with growth averaging 248.6%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.56 million (Q1 2026), $5.55 million (Q4 2025) and $43,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Agios Pharmaceuticals | 1.98 Bn | 1.98 Bn | 41.75 Mn | 3.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.98 Mn |
| Mar 31, 2026 | 5.56 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | -765,000.00 |
| Dec 31, 2024 | 991,000.00 |
| Sep 30, 2024 | -644,000.00 |
| Jun 30, 2024 | 309,000.00 |
| Mar 31, 2024 | 643,000.00 |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | -1.08 Mn |
| Jun 30, 2023 | 473,000.00 |
| Mar 31, 2023 | -428,000.00 |
| Dec 31, 2022 | 388,000.00 |
| Sep 30, 2022 | 220,000.00 |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 540,000.00 |
| Dec 31, 2017 | -372,000.00 |
| Sep 30, 2017 | 80,000.00 |
API Access
Agios Pharmaceuticals Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=AGIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "AGIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=AGIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();